Ovarian cancer progression is controlled by phenotypic changes in dendritic cells

Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm

(2011) Robert J. Kurman et al.   HUMAN PATHOLOGY

Antigen-Presenting Cell (APC) Subsets in Ovarian Cancer

(2011) Cailin Moira Wilke et al.   INTERNATIONAL REVIEWS OF IMMUNOLOGY

Integrated genomic analyses of ovarian carcinoma

(2011) D. Bell et al.   NATURE

Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion

(2011) R. D. Schreiber et al.   SCIENCE

Expression signatures of TP53 mutations in serous ovarian cancers

(2010) Marcus Q Bernardini et al.   BMC CANCER

Myeloid-Derived Suppressor Cells in Human Cancer

(2010) Srinivas Nagaraj et al.   CANCER JOURNAL

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

In situ Stimulation of CD40 and Toll-like Receptor 3 Transforms Ovarian Cancer-Infiltrating Dendritic Cells from Immunosuppressive to Immunostimulatory Cells

(2009) U. K. Scarlett et al.   CANCER RESEARCH

A Role for BRCA1 in Uterine Leiomyosarcoma

(2009) D. Xing et al.   CANCER RESEARCH

PILAR is a novel modulator of human T-cell expansion

(2008) E. Huarte et al.   BLOOD

Depletion of Dendritic Cells Delays Ovarian Cancer Progression by Boosting Antitumor Immunity

(2008) E. Huarte et al.   CANCER RESEARCH